5-HT modulation of auditory and visual sensorimotor gating: II. Effects of the 5-HT2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats

Psychopharmacology

Volumn 124, Issue 1-2, 1996, Pages 107-116

  Padich, Robert A ^a   McCloskey, Timothy C ^a   Kehne, John H ^a  

^a SANOFI   (France)

Author keywords

(+)1 4 Iodo 2,5 dimethoxyphenyl 2 aminopropane, DOI; 3,4 Methylenedioxymethamphetamine, MDMA; 5 HT2A receptor; Fenfluramine; MDL 100,907; Prepulse inhibition; Schizophrenia; Sensorimotor gating; Serotonin; Wistar rats

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; DOPAMINE 2 RECEPTOR BLOCKING AGENT; FENFLURAMINE; HALOPERIDOL; NEUROLEPTIC AGENT; PSYCHEDELIC AGENT; SEROTONIN 2A AGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 2C AGONIST; SEROTONIN AGONIST; SEROTONIN RELEASING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY STIMULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; INTRAPERITONEAL DRUG ADMINISTRATION; LIGHT; MALE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SENSORIMOTOR FUNCTION; SEROTONINERGIC SYSTEM; SOUND; VISUAL STIMULATION;

AMPHETAMINES; ANIMALS; ANTIPSYCHOTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FENFLURAMINE; FLUOROBENZENES; HALOPERIDOL; MALE; PIPERIDINES; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; STARTLE REACTION;

EID: 0029930333     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02245610     Document Type: Article

References (40)

1. 1C receptors in rat brain. J Pharmacol Exp Ther 255: 843-857
2. Berger UV, Gu XF, Azmitia EC (1992) The substituted amphetamines 3,4-methyledioxymethamphetamine, methamphetamine, p-chloroamphetamine, and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine. Eur J Pharmacol 215: 153-160
3. Braff DL, Geyer MA (1989) Sensorimotor gating and the neurobiology of schizophrenia: Human and animal model studies. In: Schultz S, Tamminga C (eds) Schizophrenia: scientific progress. Oxford University Press, NY, pp 124-136
4. Breier A (1995) Serotonin, schizophrenia and antipsychotic drug action. Schizophr Res 14: 187-202
5. Geyer MA, Swerdlow NS, Mansbach RS, Braff DL (1990) Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Res Bull 25: 485-498
6. Glennon RA (1986) Discriminative stimulus properties of the serotonergic agent 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI). Life Sci 39: 825-830
7. Glennon RA, Titeler M, Young R (1986) Structure-activity relationships and mechanism of action of hallucinogenic agents based on drug discrimination and radioligand binding studies. Psychopharmacol Bull 22: 953-958
8. Grillon C, Ameli R, Charney DS, Krystal J, Braff DL (1992) Startle gating deficits occur across prepulse intensities in schizophrenic patients. Biol Psychiatry 32: 939-943
9. Hansson LO, Waters N, Winblad B, Gottfries CG, Carlsson A (1994) Evidence for biochemical heterogenity in schizophrenia: a multivariate study of monoaminergic indices in human post-mortal brain tissue. J Neural Trans - [Gen Sect] 98: 217-235
10. Hoffman HS, Ison JR (1980) Reflex modification in the domain of startle: I. Some empirical findings and their implications for how the nervous system processes sensory input. Psychol Rev 87: 175-189
11. Judd LL, McAdams L, Budnick B, Braff DL (1992) Sensory gating deficits in schizophrenia: new results. Am J Psychiatry 4: 488-493
12. Karper LP, Freeman GK, Morgan CA, Grillon C, Charney DS, Krystal JH (1993) Prepulse inhibition of the acoustic startle response and measures of attention in schizophrenic subjects. Schizophrenia Res 9: 160
13. Kehne JH, McCloskey TC, Taylor VL, Black CK, Fadayel GM, Schmidt CJ (1992) Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats. J Pharmacol Exp Ther 260: 78-89
14. 2A antagonist with a favorable CNS safety profile. J Pharmacol Exp Ther (in press)
15. Kehne JH, Padich RA, McCloskey TC, Taylor VL, Schmidt CJ (1996b) 5-HT modulation of auditory and visual sensorimotor gating: I. Effects of 5-HT releasers on sound and light prepulse inhibition in Wistar rats. Psychopharmacology 124: 95-106
16. 2 receptors. Psychopharmacology 112: S40-S54
17. Mansbach RS (1991) Effects of NMDA receptor ligands on sensorimotor gating in the rat. Eur J Pharmacol 202: 61-66
18. Mansbach RS, Geyer MA, Braff DL (1988) Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology 94: 507-514
19. Mansbach RS, Braff DL, Geyer MA (1989) Prepulse inhibition of the acoustic startle response is disrupted by N-ethyl-3,4-methylenedioxymethamphetamine (MDEA) in the rat. Eur J Pharmacol 167:49-55.
20. 2A receptor antagonist. Eur J Pharmacol 259: 137-141
21. Meltzer H (1991) Effects of antipsychotic drugs on serotonin receptors. Pharmacol Rev 43: 587-604
22. 2 pKi values. J Pharmacol Exp Ther 251: 238-246
23. 2A antagonist. Behav Brain Res 13:163-167
24. 3 mediated control of dopaminergic function. In: Kann Rs (ed) Proceedings of American College of Neuropsychology Symposium. Psychopharmacology 112: S60-S67
25. Peroutka SJ (1994) Molecular biology of serotonin (5-HT) receptors. Synapse 18: 241-260
26. 1C receptors in the behavioral effects of the 5-HT agonist 1-(2,5-dimethoxy-4-iodophenyl aminopropane)-2 (DOI). Neurosci Lett 115: 74-80
27. Rigdon GC, Viik K (1991) Prepulse inhibition as a screening test for potential antipsychotics. Drug Dev Res 23: 91-99
28. 1A receptor agonists block prepulse inhibition of acoustic startle reflex. J Pharmacol Exp Ther 263: 486-493
29. Schmidt CJ, Kehne JH (1990) Neurotoxicity of MDMA: neurochemical effects. In: The neuropharmacology of serotonin. Ann NY Acad Sci 600: 665-681
30. Schmidt CJ, Taylor VL (1990) Reversal of the acute effects of 3,4-methylenedioxymethamphetamine by 5-HT uptake inhibitors. Eur J Pharmacol 181: 133-136
31. 2 receptors in schizophrenia and antipsychotic activity. Int Clin Psychopharmacol 8 [Suppl. 2] 25-32
32. 2A receptors in antipsychotic activity. Life Sci 56: 2209-2222
33. Sipes TA, Geyer MA (1994) Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats. Neuropharmacology 33: 441-448
34. Sipes TA, Geyer MA (1995) 8-OH-DPAT disruption of prepulse inhibition in rats: reversal with (+)WAY 100,135 and localization of site of action. Psychopharmacology 117: 41-48
35. 2 receptor antagonist MDL 100,907 as a putative antipsychotic: Behavioral, electrophysiological and neurochemical studies. J Pharmacol Exp Ther 266: 684-691
36. Swerdlow NR, Mansbach RS, Geyer MA, Pulvirenti L, Braff DL (1990) Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine. Psychopharmacology 100: 413-416
37. Swerdlow NR, Keith VA, Braff DL, Geyer MA (1991) Effects of spiperone, SCH 23390, and clozapine on apomorphine inhibition of sensorimotor gating of the startle reflex in the rat. J Pharmacol Exp Ther 256: 530-536
38. Swerdlow NR, Benbow CH, Zisook S, Geyer MA, Braff DL (1993) A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder. Biol Psychiatry 33: 298-301
39. Swerdlow NR, Paulsen J, Braff D.L, Butters N, Geyer MA, Swenson MR (1995) Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease. J Neurol Neurosurg Psychiatry 58: 192-200
40. Titeler M, Lyon RA, Davis KH, Glennon RA (1987) Selectivity of serotonergic drugs for multiple brain serotonin receptors. Biochem Pharmacol 36: 3265-3271